Verazinc
(Zinc sulfate)ApprovedSmall molecule
Zinc sulfate is used to treat zinc deficiency in the body, which can occur from poor nutrition, certain medical conditions, or as a supplement to help with wound healing and immune function.[2] Verazinc is currently approved and in use across 26 indications[4].[1]
Verazinc is one of 528 small molecule programs targeting Neonatal Jaundice. It is currently in Approved.
26
Indications
32
Total Trials
5
Active Trials
527
Competitors
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 25 indications
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1Verazinc
FFakultas Kedokteran Universitas Indonesia
Approved
Bnt162b2
BioNTechPreclinical
Stivarga
BayerPreclinical
Aimovig
AmgenPreclinical
Calciferol
Alnylam PharmaceuticalsPreclinical
Activella
Eli LillyPreclinical
Achromycin V
WWyeth-Lederle Vaccines
Preclinical
Piperacillin/tazobactam
PfizerPreclinical
Biological Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Sivelestat Sodium
TThe First Hospital of Jilin University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Acute Diarrhea3 trials
Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
Unknown status·—·Phase 2·NCT01140074·256 enrolled
Oral Zinc for the Treatment of Acute Diarrhea in US Children
Completed·—·N/A·NCT01198587·71 enrolled
Hyperbilirubinemia2 trials
Sepsis2 trials
Anemia2 trials
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Completed·—·Phase 2/3·NCT04301336·350 enrolled
21 more indications
Randomised Controlled Trial1 trial
Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial
Completed·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT05311540·195 enrolled
Jaundice1 trial
Critically Ill1 trial
Oral Mucositis1 trial
Atorvastatin1 trial
Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
Unknown status·—·Phase 2·NCT05395143·92 enrolled
Vaccine1 trial
Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Completed·—·N/A·NCT01229579·320 enrolled
Effectiveness1 trial
Hematological Malignancies1 trial
Chemoradiotherapy1 trial
Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations
Completed·—·Phase 3·NCT03824925·70 enrolled
Acceptability1 trial
Zinc Sulfate Acceptability
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·N/A·NCT04039828·325 enrolled
Hepatitis1 trial
Efficacy and Safety1 trial
Cutaneous Warts1 trial
Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts
Unknown status·—·Phase 3·NCT03158168·70 enrolled
COVID-191 trial
H Pylori Infection1 trial
Type 2 Diabetic Patients1 trial
The Effect of Zinc on the Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients
Unknown status·—·N/A·NCT03923829·34 enrolled
Unspecified1 trial
The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia
Unknown status·—·Phase 1·NCT05178953·160 enrolled
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Verazinc drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Zinc sulfate. EMBL-EBI & Wellcome Sanger Institute.
- [5]
Details